Table 1 Expression of EPO and EPOR in RCC*
From: Functional significance of erythropoietin in renal cell carcinoma
Samples | Parameters | Method | Number of samples | % expression | References |
|---|---|---|---|---|---|
Serum | EPO | ELISA | 165 | 33 | [57] |
Serum | EPO | ELISA | 49 | 8 | [58] |
Tissues | EPO | IHC# | 19 | 52 | [59] |
Tissues | EPO & EPOR | IHC | 11 | 100 | [60] |
Tissues | EPO | IHC | 20 | 100 | [61] |
Tissues | EPO | IHC | 113 | 33 | [50] |
Tissues | EPO | IHC | 82 | 88 | |
Serum | EPO & EPOR | IHC | 195 | 83 (tissue EPO) | [62] |
Tissues | Â | ELISA | Â | 33 (serum EPO)? | Â |
| Â | Â | Â | Â | 56 (tissue EPOR) | Â |